Novo Nordisk this week also announced that a pill form of the same drug found in Wegovy, generically called semaglutide, can help people lose 15% of their body weight, comparable to the weekly injections
Ozempic (active ingredient: semaglutide) Initial FDA Approval: 2017 Side Effect Update Date: November 1, 2024 Medication Description: This medication treats type 2 diabetes and is also used to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes and established cardiovascular disease
All patient stories are amalgams of real patients that I have seen in the past
Presented for research literature review only Couturier J et al
( When an injection is clearly the better choice You want the most predictable, well-studied weight-loss results
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 By raising insulin production and reducing glucagon secretion, the hormone glucagon-like peptide-1 (GLP-1) regulates blood sugar levels before and after meals